Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Johnson & Johnson
Johnson & Johnson
Newsletters
Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
By
Research Team
November 19, 2025
AI
Companies need to take a human-centric approach to AI, experts say, as executives try to shift from experimentation to implementation
By
Contributing Writer
November 17, 2025
Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript
By
Contributing Writer
October 14, 2025
Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript
By
Investment Desk
July 16, 2025
Johnson & Johnson (JNJ) Q1 2025 Earnings Call Transcript
By
Crypto Correspondent
April 15, 2025
Success
This millennial turned her passion for making PowerPoints into a $4 million business
By
Staff Writer
March 12, 2025
Newsletters
How tech leaders are rethinking their cloud strategies in the face of fast-rising costs
By
Crypto Correspondent
January 29, 2025
Mind
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
By
Financial Writer
January 23, 2025
Johnson & Johnson (JNJ) Q4 2024 Earnings Call Transcript
By
Research Team
January 22, 2025
Health
Health-care investors bank on Congress snarling RFK Jr.’s plans
By
Investment Desk
January 17, 2025
Newsletters
Coins2Day Next to Lead: The 25 Most Powerful Rising Executives in the Coins2Day 500
By
Ruth Umoh
and
Natalie McCormick
December 17, 2024
Leadership
Conservatives are using the Trump assassination attempt to slam DEI
By
Staff Writer
July 15, 2024
Newsletters
Coins2Day Archives: The day poisoned Tylenol killed three people
By
Trading Desk
June 16, 2024
Finance
Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years
By
Crypto Correspondent
May 1, 2024
Newsletters
Johnson & Johnson CIO says employee upskilling is key to transforming health care
By
Financial Writer
April 3, 2024
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Industry Analyst
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Contributing Writer
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
Market Analyst